The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
Condition(s):Hypertension; Congestive CardiomyopathyLast Updated:December 18, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Hypertension; Congestive CardiomyopathyLast Updated:December 18, 2015Completed
Condition(s):Vascular Access ComplicationLast Updated:November 24, 2021Unknown status
Condition(s):COVID 19Last Updated:April 24, 2020Unknown status
Condition(s):Cardiovascular DiseaseLast Updated:September 12, 2019Unknown status
Condition(s):Metabolic SyndromeLast Updated:January 20, 2021Completed
Condition(s):Blood Pressure; HypertensionLast Updated:January 6, 2017Completed
Condition(s):Type 1 DiabetesLast Updated:November 6, 2008Completed
Condition(s):Cord Blood Transplant; Hematologic Malignancy; Inherited Metabolic DiseaseLast Updated:August 31, 2016Withdrawn
Condition(s):IGA NephropathyLast Updated:March 17, 2009Completed
Condition(s):PreDiabetes; Impaired Glucose Tolerance; Obesity; Blood PressureLast Updated:August 14, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.